FILLMED® ART FILLER® FINE LINES with Lidocaine
$129.00
/unitNo Order Minimum
Wholesale Prices
Free Shipping Over $1000
Price Beat Available
Product details
- Brand:
- FILLMED®
- Manufacturer:
- Laboratoires FILLMED
- Active Substance(s):
- HYALURONIC ACID, LIDOCAINE
- Strength:
- 20mg/ml HA, 0.3% Lidocaine
- Pack size:
- 2 x 1ml Pre-Filled Syringe, 4 x 30 G ½ Needles
Product description
FILLMED® ART FILLER FINE LINES with Lidocaine is a viscoelastic cross-linked hyaluronic acid gel of non-animal origin gradually absorbed over time. It is colourless, transparent, sterile, non-pyrogenic and saline and contains a 0.3% volume of lidocaine hydrochloride for its anaesthetic properties. It is available in a pre-filled and single-use 1 ml syringe. Each pack contains 2 FINE LINES syringes, 4 sterile and single-use 30G½´´ needles intended for injection of FINE LINES, a product leaflet and 4 traceability labels. In order to guarantee traceability of the product, one of the two labels must be affixed to the patient file and the other must be transmitted to the patient.
Tier
| Packs | Discount (%) | For Each |
|---|---|---|
| 1 - 5 | — | $129.00 |
| 6 - 10 | 1.55 % | $127.00 |
| 11 - 20 | 2.33 % | $126.00 |
| 21+ | 3.88 % | $124.00 |
Alternative products
Check out these alternatives that might suit your needs
Shop with Confidence: Product Authenticity is Guaranteed
All products available at Doctor Medica shop are obtained from respective manufacturers and contain original LOT numbers Contact us if you have any questions about product LOT numbers.
FAQ
FILLMED® ART FILLER FINE LINES with Lidocaine is a dermal filler designed for the correction of superficial wrinkles such as crow’s feet, perioral lines, and fine forehead lines. It contains hyaluronic acid formulated using FILLMED’s patented Tri-Hyal Technology, which combines long-chain and very long-chain HA to optimize viscoelasticity and durability. The inclusion of 0.3% lidocaine ensures a more comfortable injection experience for the patient. ART FILLER FINE LINES is specifically engineered to allow precise placement in the superficial dermis, delivering natural-looking, smooth results with high safety and tolerability. Clinical trials have demonstrated sustained wrinkle correction over 12 to 18 months, with a strong safety profile and no significant risk of inflammatory nodules.
ART FILLER FINE LINES is administered intradermally using fine needles to target fine and superficial lines with precision.
Key Features:
- Specifically indicated for superficial dermal injection
- Designed for treatment of crow’s feet and fine perioral lines
Protocol:
- Inject using fine gauge needles (recommended 30G)
- Target the superficial dermis
- Volume per treatment site varies (typically 0.3–1.0 mL per area)
- Touch-ups may be done 14 days post-injection
- Re-injection possible at 6–9 months depending on patient needs
Indications:
- Correction of fine superficial wrinkles such as:
- Crow’s feet
- Fine forehead lines
- Perioral rhytides
- Crow’s feet
- Suitable for patients with early signs of aging
Contraindications:
- Hypersensitivity to hyaluronic acid or lidocaine
- Presence of active skin infections or inflammatory conditions
- Autoimmune diseases or patients on immunosuppressive therapy
Side Effects:
- Common: mild erythema, swelling, bruising at the injection site
- Rare: nodules, delayed hypersensitivity, temporary asymmetry
- Hyaluronic Acid: Non-animal origin, cross-linked
- Lidocaine: 0.3% for analgesic effect
- Concentration: ~20 mg/mL HA
- Technology: Patented Tri-Hyal formulation
- Combination of free, long-chain, and very long-chain HA
Each ART FILLER FINE LINES package includes:
- 1 pre-filled syringe of 1.0 mL
- 2 sterile 30G needles
- Package insert with full instructions and safety information
- Tamper-evident blister packaging
Yes, as with all injectable treatments, minor side effects may occur, though ART FILLER FINE LINES is well-tolerated.
Common Side Effects:
- Redness
- Mild bruising
- Localized swelling or tenderness
- Temporary discomfort
Rare Adverse Events:
- Nodules or granulomas (incidence <0.1%)
- Hypersensitivity reactions
- Post-injection asymmetry
Safety Evaluation:
- No inflammatory nodules detected in 18-month HFUS monitoring
- Excellent profile for long-term tolerability
Proper storage maintains the product’s integrity and sterility.
- Store at 2°C to 25°C
- Protect from direct sunlight and frost
- Do not use after expiration date
- Single-use only; discard any remaining product after opening



